The frequency of bronchial-pulmonary diseases in the clinics of therapeutic profile

G. Kassymova, A. Terlikbaeva (Almaty, Kazakhstan)

Source: Annual Congress 2007 - Epidemiology of tuberculosis
Session: Epidemiology of tuberculosis
Session type: Thematic Poster Session
Number: 2426
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Kassymova, A. Terlikbaeva (Almaty, Kazakhstan). The frequency of bronchial-pulmonary diseases in the clinics of therapeutic profile. Eur Respir J 2007; 30: Suppl. 51, 2426

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary diseases in prisoner patients. A one year experience of the modes of diagnosis, incidence and reccurence of pulmonary diseases and their correlation with other diseases appearing in this diverse population
Source: Eur Respir J 2006; 28: Suppl. 50, 700s
Year: 2006

Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders
Source: Eur Respir Monogr 2019; 86: 1-13
Year: 2019


The prevalence of severe asthma in specialist care –identifying eligible candidates for biological therapies
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017

School children as change agent for early diagnosis, treatment and prevention of respiratory illness and diseases
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020

Comparison of approaches in tuberculosis diagnosis between dispensary and chest disease clinics and defects into practice
Source: Eur Respir J 2006; 28: Suppl. 50, 23s
Year: 2006

The potential of palliative care for patients with respiratory diseases
Source: Breathe, 13 (4) 278; 10.1183/20734735.014217
Year: 2017



Clinical characteristics and disease control of US asthma patients treated in specialty clinics
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


A syndromic approach to assess diagnosis and management of patients presenting with respiratory symptoms to healthcare facilities in Vietnam
Source: ERJ Open Res, 7 (1) 00572-2020; 10.1183/23120541.00572-2020
Year: 2021



The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002

The burden of chronic disorders on hospital admissions prompts the need for new modalities of care
Source: Eur Respir J 2007; 30: Suppl. 51, 191s
Year: 2007

IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an "in vitro" models
Source: Annual Congress 2011 - T-cell subsets
Year: 2011


How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


Does regular physiotherapy prevent LRTIs in patients with chronic lung disease?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



Assessment of knowledge gap among primary care physicians over diagnosis of chronic airways diseases in India
Source: International Congress 2017 – Medical education, web and internet
Year: 2017


The need for a specialist multidisciplinary clinic to manage paediatric patients with severe asthma in the age of biologics
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019


Prevalence of psychiatric disorders in patients undergoing specific challenge tests for the diagnosis of occupational asthma
Source: Annual Congress 2008 - Occupational asthma - agents and management
Year: 2008

Baseline characteristics of severe asthma patients initiating biologic treatment worldwide
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019